Cronos Group Inc. (TSX:CRON)
| Market Cap | 1.28B |
| Revenue (ttm) | 184.36M |
| Net Income (ttm) | 50.28M |
| Shares Out | 382.89M |
| EPS (ttm) | 0.13 |
| PE Ratio | 25.55 |
| Forward PE | 34.18 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 198,467 |
| Average Volume | 124,957 |
| Open | 3.260 |
| Previous Close | 3.260 |
| Day's Range | 3.255 - 3.350 |
| 52-Week Range | 2.270 - 4.400 |
| Beta | 1.06 |
| RSI | 43.38 |
| Earnings Date | Nov 6, 2025 |
About Cronos Group
Cronos Group Inc., a cannabinoid company, engages in the cultivation, production, distribution, and marketing of cannabis products in Canada, Israel, and internationally. It offers dried flowers, pre-rolls, oils, vaporizers, edibles, and cannabis tinctures under the Spinach, Lord Jones, and PEACE NATURALS brand names. The company is based in Stayner, Canada. [Read more]
Full Company ProfileNews
Investing in Cannabis: Three Leading Stocks to Watch This November
The U.S. cannabis market continues to evolve as new legislative discussions, consumer trends, and business developments shape the industry's momentum. Although volatility remains, investors are increa...
3 Of The Best Marijuana Stocks To Buy For Possible Gains In 2026
The big question for marijuana stock investors is how the market will react to the newly passed bill to reverse the 2018 Farm Bill. A new bill was recently passed with language that essentially overtu...
4 Cannabis Stocks Log Momentum Gains Even As Congress Re-Criminalizes Some THC Products In Spending Bill
Four cannabis stocks are demonstrating significant technical momentum, seemingly undeterred by new regulatory headwinds from Washington. Momentum Improves For 4 Cannabis Stocks The positive trend come...
4 Cannabis Stocks Log Momentum Gains Even As Congress Re-Criminalizes Some THC Products In Spending Bill
Four cannabis stocks are demonstrating significant technical momentum, seemingly undeterred by new regulatory headwinds from Washington.
Congressional hemp restrictions threaten $28 billion industry, sending companies scrambling
The congressional funding bill included a THC cap that effectively bans most hemp products, a move industry leaders say threatens the $28 billion market. More than 300,000 jobs are at risk, with econo...
Cronos Group (CRON) Reports Record Q3 2025 Earnings
Cronos Group (CRON) Reports Record Q3 2025 Earnings
Cronos Group Inc. (CRON:CA) Q3 2025 Earnings Call Transcript
Cronos Group Inc. (CRON:CA) Q3 2025 Earnings Call November 6, 2025 8:30 AM ESTCompany ParticipantsHarrison AaronMichael Gorenstein - President, CEO &...
Cronos Group Inc (CRON) Q3 2025 Earnings Call Highlights: Record Revenue and Strategic Growth ...
Cronos Group Inc (CRON) Q3 2025 Earnings Call Highlights: Record Revenue and Strategic Growth Amid Challenges
Q3 2025 Cronos Group Inc Earnings Call Transcript
Q3 2025 Cronos Group Inc Earnings Call Transcript
Cronos Group (CRON) Reports Record Q3 Revenue and Earnings
Cronos Group (CRON) Reports Record Q3 Revenue and Earnings
Cronos Group Inc (CRON) Q3 2025 Earnings: Revenue Misses Estimates at $36.3 Million
Cronos Group Inc (CRON) Q3 2025 Earnings: Revenue Misses Estimates at $36.3 Million
Cronos Group GAAP EPS of $0.07, revenue of $36.34M misses by $0.99M
Cronos Group reports Q3 GAAP EPS of $0.07 and $36.34M revenue, up 6.1% YoY but missing estimates.
Top Canadian Cannabis Stocks to Watch in November 2025
The Canadian cannabis market continues to evolve as global demand expands and U.S. legalization remains a hot topic. Investors are watching closely as several major producers position themselves for r...
'Trump effect' raises hopes for cannabis rally as investors bet on federal reforms, softer marijuana stance
Cannabis stocks could rally on hopes for new hemp regulations and Trump's possible softer stance on marijuana, fueling investor optimism across the industry.
Cannabis Investing 2025: 3 Pot Stocks to Watch Before November
The cannabis industry continues to evolve as investors prepare for potential U.S. federal reform and international market expansion. Despite short-term volatility, global demand for both medical and r...
Cronos (CRON) Reintroduces Popular Caramel Green Apple Edible for Fall
Cronos (CRON) Reintroduces Popular Caramel Green Apple Edible for Fall
Cronos Group Inc. to Hold 2025 Third Quarter Earnings Conference Call on November 6, 2025
TORONTO, Oct. 23, 2025 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) will hold its 2025 third quarter earnings conference call on Thursday, November 6, 2...
3 Canadian Cannabis Stocks to Watch as U.S. Legalization Gains Steam in 2025
The Canadian cannabis market continues to play a crucial role in the global marijuana industry. As U.S. legalization efforts gain traction, Canadian producers are positioning themselves for renewed gr...
Cronos Group (CRON) Launches New Multipack Format for Popular Gummies
Cronos Group (CRON) Launches New Multipack Format for Popular Gummies
Cronos Group: Upside Dependent On Legal Framework Developments
Wall Street Breakfast Podcast: Weed Stocks Light Up
Cannabis stocks surged after Trump endorsed CBD for senior healthcare, citing its potential to revolutionize treatment and reduce healthcare costs. Shares of TLRY, CGC, CRON, and ACB soared double dig...
Cronos Group Reaches Analyst Target Price
In recent trading, shares of Cronos Group Inc (Symbol: CRON) have crossed above the average analyst 12-month target price of $2.95, changing hands for $2.97/share. When a stock reaches the target an a...
Cannabis stocks soar after Trump shares video promoting drug's use for seniors
Video posted on Truth Social touts CBD as a ‘gamechanger' and promotes Medicaid coverage of CBD products
Cannabis stocks surge after Trump posts video touting Medicare coverage for CBD
Tilray Brands surged nearly 20% and was up 36% after market open, while Canopy Growth jumped about 20% and Cronos Group rose 13%.
Cannabis stocks buzzing on social media post from President Trump
CNBC's Brandon Gomez joins 'Squawk on the Street' to discuss what's behind the jump in cannabis stocks.